3-D Matrix Ltd (DMTRF)

OTHER OTC:DMTRF

DMTRF

3-D Matrix

RESEARCH TOOLSreports

3-D Matrix (DMTRF) Price & Analysis

Compare

5 Followers

DMTRF Stock Chart & Stats

$2.37

-$0.42(-37.84%)

At close: Dec 12 4:00 PM EST

$2.37

-$0.42(-37.84%)

Day’s Range― - ―

52-Week Range$0.69 - $3.96

Previous CloseN/A

Volume900.00

Average Volume (3M)20.00

Market Cap

$335.97M

Enterprise Value$51.49B

Total Cash (Recent Filing)$1.49B

Total Debt (Recent Filing)$2.33B

Price to Earnings (P/E)20.6

Beta0.13

Next Earnings

Jun 11, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.05

Shares Outstanding124,965,080

10 Day Avg. Volume0

30 Day Avg. Volume20

Financial Highlights & Ratios

PEG Ratio>-0.01

Price to Book (P/B)5.64

Price to Sales (P/S)1.80

P/FCF Ratio-7.24

Enterprise Value/Market Cap153.25

Enterprise Value/Revenue6.74

Enterprise Value/Gross Profit10.20

Enterprise Value/Ebitda-70.93

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Technology & Applications3-D Matrix's proprietary self-assembling peptide platform provides a durable competitive moat across wound care, surgical aids and tissue regeneration. This platform enables multiple product pathways, licensing and partner collaborations, supporting diversified, recurring revenue and long-term market positioning.

High Gross MarginA 63.8% gross margin signals structural pricing power and cost-efficient manufacturing for peptide biomaterials. High product-level margins can fund ongoing R&D and commercialization when scale improves, improving path to sustainable operating profitability as revenues expand.

Free Cash Flow CoverageFree cash flow covering net losses suggests the company converts enough cash from operations/investing to partially offset accounting losses. This reduces immediate external funding need, extends runway for commercialization and R&D, and supports medium-term execution versus peers with worse cash conversion.

Bears Say

High LeverageA debt-to-equity ratio of 1.33 denotes meaningful financial leverage that raises interest and refinancing risk. High leverage constrains strategic flexibility, increases vulnerability to revenue shortfalls, and can crowd out investment in R&D or commercialization during adverse cycles.

Negative Operating Cash FlowPersistent negative operating cash flow signals the core business is not yet self-sustaining, requiring reliance on financing or asset sales to fund growth. Over time this can erode balance sheet resilience, limit investment in scale-up, and elevate default or dilution risk if not corrected.

Ongoing Net Losses & Negative ROEConsistent net losses and negative ROE show the company has not converted its technology advantage into shareholder returns. Without clear path to positive operating margins, the firm risks continued capital raises, investor fatigue and constrained ability to finance long-term clinical or commercial investments.

3-D Matrix News

3-D Matrix and Harvard Achieve Breakthrough in Cardiac Regenerative Therapy

The latest announcement is out from 3-D Matrix ( ($JP:7777) ). 3-D Matrix, Ltd. has achieved a significant...

5M ago

DMTRF FAQ

What was 3-D Matrix Ltd’s price range in the past 12 months?

3-D Matrix Ltd lowest stock price was $0.69 and its highest was $3.96 in the past 12 months.

What is 3-D Matrix Ltd’s market cap?

3-D Matrix Ltd’s market cap is $335.97M.

When is 3-D Matrix Ltd’s upcoming earnings report date?

3-D Matrix Ltd’s upcoming earnings report date is Jun 11, 2026 which is in 75 days.

How were 3-D Matrix Ltd’s earnings last quarter?

3-D Matrix Ltd released its earnings results on Dec 11, 2025. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of N/A by $0.05.

Is 3-D Matrix Ltd overvalued?

According to Wall Street analysts 3-D Matrix Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does 3-D Matrix Ltd pay dividends?

3-D Matrix Ltd does not currently pay dividends.

What is 3-D Matrix Ltd’s EPS estimate?

3-D Matrix Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does 3-D Matrix Ltd have?

3-D Matrix Ltd has 124,965,080 shares outstanding.

What happened to 3-D Matrix Ltd’s price movement after its last earnings report?

3-D Matrix Ltd reported an EPS of $0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of 3-D Matrix Ltd?

Currently, no hedge funds are holding shares in DMTRF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

3-D Matrix Ltd

3-D Matrix, Ltd. develops self-assembling peptide technology. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the fields of regenerative medicine, cell therapy, drug delivery technology, and surgical treatment. The company was founded in 2004 and is based in Tokyo, Japan.